DOD Biotech (Thailand) Market Value
| DOD Stock | 1.95 0.01 0.51% |
| Symbol | DOD |
DOD Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DOD Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DOD Biotech.
| 11/15/2024 |
| 12/15/2024 |
If you would invest 0.00 in DOD Biotech on November 15, 2024 and sell it all today you would earn a total of 0.00 from holding DOD Biotech Public or generate 0.0% return on investment in DOD Biotech over 30 days. DOD Biotech is related to or competes with Carabao Group, Jay Mart, Gulf Energy, KCE Electronics, and Mega Lifesciences. More
DOD Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DOD Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DOD Biotech Public upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.52 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 25.23 | |||
| Value At Risk | (4.38) | |||
| Potential Upside | 6.84 |
DOD Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DOD Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DOD Biotech's standard deviation. In reality, there are many statistical measures that can use DOD Biotech historical prices to predict the future DOD Biotech's volatility.| Risk Adjusted Performance | 0.0123 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0174 |
DOD Biotech Public Backtested Returns
DOD Biotech Public secures Sharpe Ratio (or Efficiency) of -0.37, which denotes the company had a -0.37% return per unit of risk over the last 3 months. DOD Biotech Public exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm DOD Biotech's Coefficient Of Variation of 17741.09, mean deviation of 2.3, and Downside Deviation of 2.52 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.75, which means possible diversification benefits within a given portfolio. As returns on the market increase, DOD Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding DOD Biotech is expected to be smaller as well. At this point, DOD Biotech Public has a negative expected return of -0.77%. Please make sure to confirm DOD Biotech's downside deviation, information ratio, and the relationship between the semi deviation and coefficient of variation , to decide if DOD Biotech Public performance from the past will be repeated in the future.
Auto-correlation | 0.64 |
Good predictability
DOD Biotech Public has good predictability. Overlapping area represents the amount of predictability between DOD Biotech time series from 15th of November 2024 to 30th of November 2024 and 30th of November 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DOD Biotech Public price movement. The serial correlation of 0.64 indicates that roughly 64.0% of current DOD Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.64 | |
| Spearman Rank Test | 0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
DOD Biotech Public lagged returns against current returns
Autocorrelation, which is DOD Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DOD Biotech's stock expected returns. We can calculate the autocorrelation of DOD Biotech returns to help us make a trade decision. For example, suppose you find that DOD Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
DOD Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DOD Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DOD Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DOD Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
DOD Biotech Lagged Returns
When evaluating DOD Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DOD Biotech stock have on its future price. DOD Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DOD Biotech autocorrelation shows the relationship between DOD Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in DOD Biotech Public.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in DOD Stock
DOD Biotech financial ratios help investors to determine whether DOD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOD with respect to the benefits of owning DOD Biotech security.